α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy-Reference-Cited by-同舟云学术

α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy

Published:2019-02-28 Issue:4 Volume:16 Page:1541-1554
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Bhatt Himanshu¹,Kiran Rompicharla Sri Vishnu¹,Ghosh Balaram¹^ORCID,Biswas Swati¹^ORCID

Affiliation:

1. Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Medchal, Hyderabad, Telangana 500078, India

Funder

Council for Scientific and Industrial Research

Department of Biotechnology , Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01232

Reference42 articles.

1. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting

2. Dendrimer as nanocarrier for drug delivery

3. Dendrimers:

4. Preliminary biological evaluation of polyamidoamine (PAMAM) StarburstTM dendrimers

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on dendrimer-based nanoconjugates and their intracellular trafficking in cancer photodynamic therapy;Artificial Cells, Nanomedicine, and Biotechnology;2024-08-05

2. Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Carbosilane Dendritic Amphiphiles from Cholesterol or Vitamin E for Micelle Formation;Pharmaceutics;2024-03-25

4. Exploring the Potential of Nano Drug Delivery Systems in Non-Small Cell Lung Cancer Treatment: Recent Developments and Perspectives;Current Drug Therapy;2024-03-01

5. Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer;International Journal of Biological Macromolecules;2024-01